c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.

c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.

The aim of this study was to determine the incidence and clinicopathological significance of c-MYC gene copy-number (GCN) gain in patients with primary colorectal cancer (CRC).The c-MYC GCN was investigated in 367 consecutive CRC patients (cohort 1) by using dual-color silver in situ hybridization....

Full description

Bibliographic Details
Main Authors:	Kyu Sang Lee, Yoonjin Kwak, Kyung Han Nam, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Woo Ho Kim, Hye Seung Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4591346?pdf=render

Similar Items

Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
by: Yoonjin Kwak, et al.
Published: (2017-08-01)

HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.
by: An Na Seo, et al.
Published: (2014-01-01)

Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases
by: Kyu Sang Lee, et al.
Published: (2016-07-01)

The clinical implication of cancer-associated microvasculature and fibroblast in advanced colorectal cancer patients with synchronous or metachronous metastases.
by: Yoonjin Kwak, et al.
Published: (2014-01-01)

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
by: Soo Kyung Nam, et al.
Published: (2016-01-01)

The Role of MYC Rearrangements and Relative Copy Number Gain in Prostate Cancer
by: Maria Pedro Pessoa de Barros Pereira da Silva
Published: (2019)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
by: Sumi Yun, et al.
Published: (2021-06-01)

Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.
by: Min Hwan Kim, et al.
Published: (2015-01-01)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
by: Hye Jung Hwang, et al.
Published: (2020-09-01)

Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
by: Kyu Sang Lee, et al.
Published: (2021-05-01)

<i>FAK</i>-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer
by: Young-Ho Kim, et al.
Published: (2019-09-01)

Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer—Integrative Analysis of TCGA Data
by: Eun Kyung Choe, et al.
Published: (2021-02-01)

Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
by: Guk Jin Lee, et al.
Published: (2021-03-01)

Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer
by: Bo Gun Jang, et al.
Published: (2020-04-01)

Prognostic factors of restrictive myopathy in thyroid eye disease
by: Jae Hwan Choi, et al.
Published: (2021-07-01)

Does Colonic Diverticulosis Raise the Risk of Colorectal Adenoma in Patients with Colorectal Cancer?
by: Yeon-Ji Kim, et al.
Published: (2019-01-01)

GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumors.
by: Eui Jin Lee, et al.
Published: (2013-01-01)

Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer.
by: Young Jin Yoo, et al.
Published: (2020-01-01)

Simultaneous copy number gains of <it>NUPR1</it> and <it>ERBB2</it> predicting poor prognosis in early-stage breast cancer
by: Jung Seung-Hyun, et al.
Published: (2012-08-01)

Digital PCR for the Analysis of MYC Copy Number Variation in Lung Cancer
by: Alexander Brik, et al.
Published: (2020-01-01)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
by: Hye Eun Park, et al.
Published: (2021-07-01)

MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
by: Joon Im, et al.
Published: (2021-03-01)

Prognostic Relevance of HJURP Expression in Patients with Surgically Resected Colorectal Cancer
by: Dong Hyun Kang, et al.
Published: (2020-10-01)

Immunohistochemistry for myc predicts survival in colorectal cancer.
by: Christopher W Toon, et al.
Published: (2014-01-01)

Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.
by: Jee-Yon Lee, et al.
Published: (2017-01-01)

CD9 Expression in Colorectal Carcinomas and Its Prognostic Significance
by: Kyung-Ju Kim, et al.
Published: (2016-11-01)

Subconjunctival and Orbital Silicone Oil Granuloma (Siliconoma) Complicating Intravitreal Silicone Oil Tamponade
by: Jung Hye Lee, et al.
Published: (2014-01-01)

c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma
by: S.M.F. Brenna, et al.
Published: (2002-04-01)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
by: Changhoon Song, et al.
Published: (2018-09-01)

Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study
by: Chul Seung Lee, et al.
Published: (2020-08-01)

The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer.
by: Zhihai Mao, et al.
Published: (2013-01-01)

Tumor immune response and immunotherapy in gastric cancer
by: Yoonjin Kwak, et al.
Published: (2020-01-01)

The MYC 3′ Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells
by: Sherri A. Rennoll, et al.
Published: (2016-05-01)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
by: Kim Mi-Jung, et al.
Published: (2012-08-01)

Structural and Biophysical Analyses of Human N-Myc Downstream-Regulated Gene 3 (NDRG3) Protein
by: Kyung Rok Kim, et al.
Published: (2020-01-01)

The prognostic role of aberrant copy number of <i>DDB1, PRPF19, CDKN1B, с-Myc</i> genes in ovarian cancer patients
by: E. V. Verenikina, et al.
Published: (2021-07-01)

Expression of c-MET in Invasive Meningioma
by: Sumi Yun, et al.
Published: (2015-01-01)

Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer.
by: Han-Seong Kim, et al.
Published: (2014-01-01)

Colonic Chicken Skin Mucosa is an Independent Endoscopic Predictor of Advanced Colorectal Adenoma
by: Eun Ju Chung, et al.
Published: (2015-10-01)

Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea
by: Ji-Hye Park, et al.
Published: (2020-05-01)